Collegium Pharmaceutical, Inc. (COLL) CEO Joseph Ciaffoni on Q2 2021 Results – Earnings Call Transcript

Collegium Pharmaceutical, Inc. (COLL) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET
Company Participants
Alex Dasalla – Head, IR
Joseph Ciaffoni – President, CEO & Director
Colleen Tupper – EVP & CFO
Scott Dreyer – EVP & Chief Commercial Officer

Click here to view the original article.